Document:

THE VAN DE KAMP GROUP, LLC
                          100 Seaview Avenue, Suite 4B
                                Norwalk,CT 06855
                                 (203) 857-4887

September 27, 2005

Mr. Bruce Haglund
Chairman & CEO
Dermisonics, Inc.
Four Tower Bridge
200 Bar-Harbor Drive
West Conshohocken, PA 19428

Re: Dermisonics Plan

Dear Mr. Haglund:

This letter shall serve as an agreement between Dermisonics, Inc. (the Client)
and THE VAN DE KAMP GROUP, LLC (the Group) governing the provision of consulting
services relative to the preparation of a business plan for Dermisonics.

1.   The Group will prepare the first draft of the plan, which will include:
     -    VISION/MISSION - This captures the essential concept of the Company,
          its primary goals, and how it plans to achieve them.
     -    EXECUTIVE SUMMARY - This will highlight the key sections of the
          business plan.
     -    BUSINESS STRATEGY - An assessment of the business opportunities
          inherent in the medical and cosmetic applications of "The U-Strip Drug
          Delivery System", the Company's proprietary, ultrasonically assisted
          transdermal delivery technology, and the strategies designed to
          exploit it.
     -    COMPANY OVERVIEW - A description of the Company, its legal structure,
          management team and strategic alliances.
     -    PRODUCT STRATEGY - A detailed discussion of "The U-Strip Drug Delivery
          System", its benefits, competitive advantages and future
          products/services planned if any.
     -    MARKET ANALYSIS - Overview of the non-invasive drug delivery device
          market and its cosmetic extensions, their size, growth, major trends,
          key segments, customer profiles, prospective Company's Strengths &
          Weaknesses, Opportunities, and Competitive Landscape.
     -    MARKETING PLAN - Marketing, Branding, Advertising, Promotion, Public
          Relations and Sales Objectives and Strategies plus Development
          Timetable.
2.   Upon completion of this first draft and its approval by the Client, the
     Group will be responsible for all-final revisions and editing.
3.   This plan will not include pro-forma financial statements and projections,
     which will be the responsibility of the Client.
4.   The Client shall provide to the Group data and information in verbal and
     written form as required and appropriate, to enable the Group to
     successfully complete its assignment

Fax: (203) 866-1337   E-mail: tedvdk@attglobal.net   URL: www.vandekampgroup.com
                              --------------------

<PAGE>
The Client shall compensate the Group for preparation of the plan in the form of
a combined fee of cash and stock with an initial value of $20,000 broken down as
follows:
     1    $10,000 in cash payable upon execution and delivery of this agreement,
          and
     2    11,765 Common shares in the capital stock of Dermisonics with a market
          value of $10,000 on the date of execution of this agreement. The
          Company undertakes to include the common shares so issued in the first
          registration statement the Company files with the Securities Exchange
          Commission subsequent to the date of execution of this agreement.

The Client further agrees to pay for all pre-approved outside expenses, relevant
to the Group's project work such as, but not limited to, market research, travel
and other out-of-pocket expenses incurred by the Group resulting from this
Agreement The Group is an independent consultant. Nothing contained in this
Agreement shall be deemed or interpreted to constitute the Group as a partner,
agent or employee of the Client, nor shall either party have any authority to
bind the other. It is agreed between the parties that there are no other
agreements or understandings between them relating to the subject matter of this
Agreement. Otherwise, this Agreement supersedes all prior agreements, oral or
written, between the parties and is intended as a complete and exclusive
statement of the agreement between the parties. No change or modification of
this Agreement shall be valid unless the same is in writing and signed by the
parties.

The VAN DE KAMP GROUP, LLC shall not be responsible for any claims or content in
the business plan relating to any information that has been furnished by the
Client. Further, the Client agrees to indemnify the Group against any and all
losses, claims damages, liabilities or expenses (including legal fees) relating
thereto.

If the terms of this agreement meet with your acceptance, please indicate same
by signing below in the space provided and return one signed original copy of
this agreement. Please wire the initial $10,000 payment to:
     -   Citibank ABA:          221172610
     -    Account:              THE VAN DE KAMP GROUP, Account #: 22431506

Very truly yours,

/s/ Theodore J van de Kamp

Theodore J. van de Kamp
Chairman & CEO

Accepted and agreed to upon this 27th day of September 2005.
                                 ----

By:  /s/ Bruce Haglund
     ------------------
     Mr. Bruce Haglund
     Chairman & CEO

Fax: (203) 866-1337   E-mail: tedvdk@attglobal.net   URL: www.vandekampgroup.com
                              --------------------THE VAN DE KAMP GROUP, LLC
                          100 Seaview Avenue, Suite 4B
                                Norwalk, CT 06855
                                 (203) 857-4887

November 3, 2005

Mr. Bruce Haglund
Chairman & CEO
Dermisonics, Inc.
Four Tower Bridge
200 Bar-Harbor Drive
West Conshohocken, PA 19428

Dear Mr. Haglund:

This letter shall serve as an agreement between Dermisonics, Inc. (the Client)
and The Van De Kamp Group, LLC (the Group) governing the provision of consulting
services relative to the preparation of all documents required by Dermisonics in
support of the investor relations programs being run on behalf of Dermisonics by
Trilogy Capital Partners and Malves Financial S.A. in conjunction with the
offering by Dermisonics of certain securities in reliance upon the exemption to
the registration requirements of the Securities Act of 1933 provided by
Regulation S as promulgated hereunder (the "Offering")

The Group will prepare and submit to Dermisonics all documents requested by
Dermisonics in support of the Offering and, in addition, provide the following
support services throughout the term of this Consulting Agreement:

-    BUSINESS STRATEGY - An assessment of the business opportunities inherent
     in the medical and cosmetic applications of the "U-Strip Drug Delivery
     System", the "U-Wand Cosmetic Device" and the "A-Wand Antiseptic
     Applicator", the Client's proprietary, ultrasonically assisted transdermal
     delivery technologies, and the strategies designed to exploit them;
-    PRODUCT STRATEGY - A detailed discussion of "The U-Strip Drug Delivery
     System", its benefits, competitive advantages and future products/services
     planned if any;
-    MARKET ANALYSIS - An overview of the non-invasive drug  delivery  device
     market  and  its cosmetic extensions, their size, growth, major trends, key
     segments,  customer profiles, prospective Company's Strengths & Weaknesses,
     Opportunities, and Competitive Landscape;
-    MARKETING PLAN - Marketing, Branding, Advertising, Promotion, Public
     Relations and Sales Objectives and Strategies plus Development Timetable;
     and
-    Such other documents as may be required by the Client in support of the
     Offering.

Upon  completion  of  any  first draft and its approval by the Client, the Group
will  be  responsible  for  all-final  revisions  and  editing.

Fax: (203) 866-1337   E-mail: tedvdk@attglobal.net   URL: www.vandekampgroup.com
                              --------------------

<PAGE>
The Client shall provide to the Group data and information in verbal and written
form as required and appropriate, to enable the Group to successfully complete
its assignment.

The Client shall compensate the Group for preparation and finalization of all
documents requested by the Client in support of the Offering throughout the term
of this consulting agreement by the issuance and delivery of 20,000 common
shares in the capital stock of the Client (the "Shares") provided, however, that
the Shares be registered on a Form S-8 by the Client as soon after the execution
of this consulting agreement as is practically possible.

The Client further agrees to pay for all pre-approved outside expenses, relevant
to the Group's project work such as, but not limited to, market research, travel
and other out-of-pocket expenses incurred by the Group resulting from this
Agreement.

The Group is an independent consultant. Nothing contained in this Agreement
shall be deemed or interpreted to constitute the Group as a partner, agent or
employee of the Client, nor shall either party have any authority to bind the
other. It is agreed between the parties that there are no other Agreements or
understandings between them relating to the subject matter of this Agreement.
Otherwise, this Agreement supersedes all prior Agreements, oral or written,
between the parties and is intended as a complete and exclusive statement of the
Agreement between the parties. No change or modification of this Agreement shall
be valid unless the same is in writing and signed by the parties.

The Van De Kamp Group, LLC shall not be responsible for any claims or content in
the business plan relating to any information that has been furnished by the
Client. Further, the Client agrees to indemnify the Group against any and all
losses, claims damages, liabilities or expenses (including legal fees) relating
thereto.

If the terms of this agreement meet with your acceptance, please indicate same
by signing below in the space provided and return one signed original copy of
this Agreement.

Very truly yours,

/s/ Theodore J. van de Kamp
Theodore J. van de Kamp
Chairman & CEO

Accepted and agreed to upon this _____day of November 2005.

By:
     --------------------------------
     Mr. Bruce Haglund
     Chairman & CEO

Fax: (203) 866-1337   E-mail: tedvdk@attglobal.net   URL: www.vandekampgroup.com
                              --------------------

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}]]